Influence of Androgen Deprivation Therapy on the Development of Sarcopenia in Patients with Prostate Cancer: A Systematic Review
- PMID: 38474784
- PMCID: PMC10934555
- DOI: 10.3390/nu16050656
Influence of Androgen Deprivation Therapy on the Development of Sarcopenia in Patients with Prostate Cancer: A Systematic Review
Abstract
The changes in body composition during androgen deprivation therapy (ADT) in patients suffering from prostate cancer (PCa) are recognized by professionals more often as biomarker for effective treatment. The aim of this study was to investigate the impact of ADT on the sarcopenia development in PCa. The following databases were used: PubMed, Embase, Web of Science and Scopus databases. Out of 2183 studies, 7 were included in this review. The fixed-effect model was used in the meta-analysis. A significant increase in SATI (Subcutaneous Adipose Tissue Index) of 0.32 (95% CI: 0.13-0.51) p = 0.001, decrease in SMI (Skeletal Muscle Index) of -0.38 (95% CI: -0.57 to -0.19) p < 0.0001, and SMD (Skeletal Muscle Density) of -0.46 (95% CI: -0.69 to -0.24) p < 0.0001 were observed. No statistical association was visible between ADT and changes in BMI (Body Mass Index), 0.05 (95% CI: -0.18-0.28), p = 0.686, and VATI (Visceral Adipose Tissue Index): 0.17 (95% CI: -0.02 to 0.37), p = 0.074. In conclusion, the ADT significantly contributes to the body composition changes and sarcopenia development.
Keywords: ADT; androgen deprivation therapy; prostate cancer; prostatic neoplasm; sarcopenia; systematic review.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






References
-
- Sathianathen N.J., Oestreich M.C., Brown S.J., Gupta S., Konety B.R., Dahm P., Kunath F. Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer. Cochrane Database Syst. Rev. 2020;12:CD013245. doi: 10.1002/14651858.CD013245. - DOI - PMC - PubMed
-
- Lopez P., Newton R.U., Taaffe D.R., Singh F., Buffart L.M., Spry N., Tang C., Saad F., Galvão D.A. Associations of Fat and Muscle Mass with Overall Survival in Men with Prostate Cancer: A Systematic Review with Meta-Analysis. Prostate Cancer Prostatic Dis. 2022;25:615–626. doi: 10.1038/s41391-021-00442-0. - DOI - PMC - PubMed
-
- Ussing A., Mikkelsen M., Villumsen B., Wejlgaard J., Bistrup P., Birkefoss K., Bandholm T. Supervised Exercise Therapy Compared with No Exercise Therapy to Reverse Debilitating Effects of Androgen Deprivation Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-Analysis. Prostate Cancer Prostatic Dis. 2022;25:491–506. doi: 10.1038/s41391-021-00450-0. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical